GlaxoSmithKline CR`s Gross Margin reached 11.6 % in 2017. This is 2.19 % more than in the previous year.
Buy Gross Margin data for GlaxoSmithKline Czech Republic.
$19.99Buy all data for GlaxoSmithKline Czech Republic.
Buy annual subscriptions for all our products.
| Company | Unit | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| Amgen Czech Republic | % | ... | ... | ... | ... | ... | 41.9 | 37.0 | 33.9 | 26.6 | 26.3 | ||||||||
| Bayer Czech Republic | % | ... | ... | ... | 0.050 | 11.5 | 13.1 | 12.3 | 13.8 | ||||||||||
| GlaxoSmithKline Czech Republic | % | ... | ... | ... | 10.7 | 12.4 | 11.5 | 12.3 | 11.4 | ||||||||||
| Merck Czech Republic | % | ... | ... | 14.3 | 13.1 | 10.7 | 11.2 | 14.2 | |||||||||||
| Novartis Czech Republic | % | 10.2 | 11.1 | 12.3 | 15.1 | 14.4 | |||||||||||||
| Pfizer Czech Republic | % | ... | ... | 11.1 | 9.20 | 9.29 | 9.61 | 9.96 | |||||||||||
| Roche Czech Republic | % | ... | ... | ... | 12.4 | 13.0 | 15.6 | 17.5 | 27.3 | ... | |||||||||
| Sanofi-Aventis Czech Republic | % | ... | ... | ... | ... | 7.61 | 7.95 | 9.26 | 7.93 | 10.5 | |||||||||
| Servier Czech Republic | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 55.0 | 47.7 | 43.3 | 30.2 | ||
| Walmark | % | ... | ... | ... | 71.2 | 70.1 | 68.8 | 72.6 | 15.8 |
Helgi Library 
